Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02715778 · ClinicalTrials.gov registry record
Translational Investigation of Gestational Environment on Neurobehavioral Function in Children
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 95
- Enrollment target
NCT02715778: Completed study, sponsored by Massachusetts General Hospital.
NCT02715778 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 95 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02715778 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 95 participants
- Enrollment target
Study Summary
Although the last decade has brought major advances with respect to our knowledge of certain risks associated with fetal exposure to psychiatric medications, critical information regarding the long-term neurobehavioral impact of fetal exposure is lacking. With a prevalence rate of selective serotonin reuptake inhibitor (SSRI) use across pregnancy in Western countries noted to be as high as 5-8%, this study aims to close the gap in knowledge regarding long-term neurobehavioral sequelae of in utero exposure to this class of antidepressants. Importantly, the assessment of the impact of antenatal psychotropic medication use must be conducted with an appreciation of the potential direct and indirect effects of maternal psychiatric illness during pregnancy and throughout childhood. The outcomes of this study will help to inform the care of reproductive age women treated with psychiatric medications as they, along with the clinicians prescribing for them, weigh the relative risks of using these agents during pregnancy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2016-02 |
| Est. Completion | 2019-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02715778
The ClinicalTrials.gov registry entry for NCT02715778 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02715778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02715778 about?
NCT02715778 is a clinical study titled "Translational Investigation of Gestational Environment on Neurobehavioral Function in Children". Although the last decade has brought major advances with respect to our knowledge of certain risks associated with fetal exposure to psychiatric medications, critical information regarding the long-term neurobehavioral impact of fetal exposure is lacking. With a prevalence rate of selective serotoni...
What is the current status of trial NCT02715778?
This trial is currently completed. The enrollment target is 95 participants. The study started on 2016-02. Estimated completion is 2019-06.
Who is sponsoring clinical trial NCT02715778?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.